CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Claret says it latest fund will have larger focus on European life sciences 

Positive
AI Analysis

Summary

Claret Capital Partners has raised €575 million in its Fund IV, with a significant portion designated for lending to European biotech companies and manufacturers.

Importance:3/10
Sentiment:
0.50
fundraisingEuropean life sciencesbiotech fundingventure capital

Read the original article

Published by Endpoints News on September 7, 2026 5:00 AM

Read Original